In a recent study we demonstrated that vildagliptin in combination with insulin reduced glucagon levels at hyperglycemia and sustained the glucagon counterregulation to hypoglycemia, which yielded lower glucose levels at hyperglycemia and prevention of hypoglycemia in type 2 diabetes [21]. This evidence concerns the gene INS and type 2 diabetes mellitus.